Exact Mass: 331.2722

Exact Mass Matches: 331.2722

Found 113 metabolites which its exact mass value is equals to given mass value 331.2722, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-hydroxydecanoyl carnitine

3-[(3-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


3-Hydroxydecanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxydecanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxydecanoylcarnitine

3-[(7-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


7-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxydecanoylcarnitine

3-[(6-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


6-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Hydroxydecanoylcarnitine

3-[(2-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


2-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 2-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Hydroxydecanoylcarnitine

3-[(8-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


8-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydecanoylcarnitine

3-[(5-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


5-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Hydroxydecanoylcarnitine

3-[(4-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


4-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Hydroxydecanoylcarnitine

3-[(9-hydroxydecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


9-Hydroxydecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-hydroxydecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Hydroxydecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 9-Hydroxydecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Methylfuntumine

N-Methylfuntumine

C22H37NO (331.2875)


   

Holaphyllinol

Holaphyllinol

C22H37NO (331.2875)


   

oxaloterpin E

oxaloterpin E

C21H33NO2 (331.2511)


   

Dovyalicine B

Dovyalicine B

C19H29N3O2 (331.226)


   

15alpha-Hydroxyholamine

(+)-15alpha-Hydroxyholamine

C21H33NO2 (331.2511)


   
   

3-Oxime- Pregnane-3,20-dione

3-Oxime- Pregnane-3,20-dione

C21H33NO2 (331.2511)


   

(Z)-N-<2-(4-hydroxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide|(Z)-N-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enamide

(Z)-N-<2-(4-hydroxyphenyl)ethyl>-3-methyldodec-2-enamide|(Z)-N-[2-(4-Hydroxyphenyl)-ethyl]-3-methyl-2-dodecenamide|(Z)-N-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enamide

C21H33NO2 (331.2511)


   

N(1)-acetyl-N(1)-deoxymayfoline

N(1)-acetyl-N(1)-deoxymayfoline

C19H29N3O2 (331.226)


   

20-(methylamino)pregn-5-en-3-ol

20-(methylamino)pregn-5-en-3-ol

C22H37NO (331.2875)


   

Funtumafrine B

Funtumafrine B

C22H37NO (331.2875)


   

(+)-elisabethamine|elisabethamine

(+)-elisabethamine|elisabethamine

C21H33NO2 (331.2511)


   

10-Isothiocyanatobiflora-4,15-diene

10-Isothiocyanatobiflora-4,15-diene

C21H33NS (331.2334)


   

(3aR)-3c-methyl-4t-[trans-2-((2S)-6t-methyl-piperidin-2r-yl)-vinyl]-(3ar,4ac,8ac,9ac)-decahydro-naphtho[2,3-c]furan-1-one|(3S,3aR,4R,4aS,8aR,9aS)-decahydro-3-methyl-4-[2-(E)-[(2S,6R)-6-methylpiperidin-2-yl]ethenyl]naphtho[2,3-c]furan-1(3H)-one|Himandravin|Himbelin|Himbeline|Himbellin

(3aR)-3c-methyl-4t-[trans-2-((2S)-6t-methyl-piperidin-2r-yl)-vinyl]-(3ar,4ac,8ac,9ac)-decahydro-naphtho[2,3-c]furan-1-one|(3S,3aR,4R,4aS,8aR,9aS)-decahydro-3-methyl-4-[2-(E)-[(2S,6R)-6-methylpiperidin-2-yl]ethenyl]naphtho[2,3-c]furan-1(3H)-one|Himandravin|Himbelin|Himbeline|Himbellin

C21H33NO2 (331.2511)


   

(-)-(2R*,3S*,6S*)-N,2-dimethyl-3-hydroxy-6-(9-phenylnonyl)piperidine

(-)-(2R*,3S*,6S*)-N,2-dimethyl-3-hydroxy-6-(9-phenylnonyl)piperidine

C22H37NO (331.2875)


   
   
   

batzellaside A

batzellaside A

C18H37NO4 (331.2722)


   

Holaphyllidine

Holaphyllidine

C22H37NO (331.2875)


   

(6Z,9Z,12Z,15Z)-1-(diethylamino)octadeca-6,9,12,15-tetraen-3-one

(6Z,9Z,12Z,15Z)-1-(diethylamino)octadeca-6,9,12,15-tetraen-3-one

C22H37NO (331.2875)


   

20-Oxime- Pregnane-3,20-dione

20-Oxime- Pregnane-3,20-dione

C21H33NO2 (331.2511)


   

caldaphnidine M

caldaphnidine M

C21H33NO2 (331.2511)


   

Dihydrolatifolin

Dihydrolatifolin

C22H37NO (331.2875)


   

DTXSID40694028

DTXSID40694028

C22H37NO (331.2875)


   

phenylethylamide 331

phenylethylamide 331

C22H37NO (331.2875)


   

N-ethyl arachidonoylamide

N-ethyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H37NO (331.2875)


   

N,N-dimethylarachidonoylamide

N,N-dimethyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H37NO (331.2875)


   
   
   
   
   

CAR 10:0;O

3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate

C17H33NO5 (331.2359)


   

NA 22:4

N,N-dimethyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H37NO (331.2875)


   

SPB 19:0;O3

(2S,3S,4R)-2-Amino-17-methyl-1,3,4-octadecanetriol

C19H41NO3 (331.3086)


   

trans-4-(4-Pentylcyclohexyl)-4-biphenylcarbonitrile

trans-4-(4-Pentylcyclohexyl)-4-biphenylcarbonitrile

C24H29N (331.23)


   

1,9-BIS-BOC-1,5,9-TRIAZANONANE

1,9-BIS-BOC-1,5,9-TRIAZANONANE

C16H33N3O4 (331.2471)


   

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PIPERIDINE

1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)PIPERIDINE

C19H30BNO3 (331.2319)


   

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

C19H33N3Si (331.2444)


   

Hexadecanamide,N-phenyl-

Hexadecanamide,N-phenyl-

C22H37NO (331.2875)


   

4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propyl]morpholine

4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propyl]morpholine

C19H30BNO3 (331.2319)


   

N-{3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyoxy]propyl}pyrrolidine

N-{3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyoxy]propyl}pyrrolidine

C19H30BNO3 (331.2319)


   

1,5-bis-Boc-1,5,9-triazanonane

1,5-bis-Boc-1,5,9-triazanonane

C16H33N3O4 (331.2471)


   

2-[bis(2-hydroxyethyl)amino]ethyl laurate

2-[bis(2-hydroxyethyl)amino]ethyl laurate

C18H37NO4 (331.2722)


   

hexa-n-propyl phosphorous triamide

hexa-n-propyl phosphorous triamide

C18H42N3P (331.3116)


   
   

(3S,4S)-3,4-BIS[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]PYRROLIDINE

(3S,4S)-3,4-BIS[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]PYRROLIDINE

C16H37NO2Si2 (331.2363)


   

N-(2-Phenylethyl)tetradecanamide

N-(2-Phenylethyl)tetradecanamide

C22H37NO (331.2875)


   

(8r)-8-[(Dimethylamino)methyl]-1-[3-(Dimethylamino)propyl]-1,7,8,9-Tetrahydrochromeno[5,6-D]imidazol-2-Amine

(8r)-8-[(Dimethylamino)methyl]-1-[3-(Dimethylamino)propyl]-1,7,8,9-Tetrahydrochromeno[5,6-D]imidazol-2-Amine

C18H29N5O (331.2372)


   

Arachidonoyl-N,N-dimethyl amide

Arachidonoyl-N,N-dimethyl amide

C22H37NO (331.2875)


   

(7Z,10Z,13Z,16Z)-Docosatetraenoate

(7Z,10Z,13Z,16Z)-Docosatetraenoate

C22H35O2- (331.2637)


   

9,10,18-Trihydroxystearate

9,10,18-Trihydroxystearate

C18H35O5- (331.2484)


   

7-Hydroxydecanoylcarnitine

7-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

6-Hydroxydecanoylcarnitine

6-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

2-Hydroxydecanoylcarnitine

2-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

8-Hydroxydecanoylcarnitine

8-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

5-Hydroxydecanoylcarnitine

5-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

4-Hydroxydecanoylcarnitine

4-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

9-Hydroxydecanoylcarnitine

9-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


   

[2-(8-Amino-7-oxononanoyl)oxy-3-carboxypropyl]-trimethylazanium

[2-(8-Amino-7-oxononanoyl)oxy-3-carboxypropyl]-trimethylazanium

C16H31N2O5+ (331.2233)


   

3-Hydroxydecanoylcarnitine

3-Hydroxydecanoylcarnitine

C17H33NO5 (331.2359)


An O-acylcarnitine having 3-hydroxydecanoyl as the acyl substituent.

   

3-(3-hydroxypropylamino)-7-methyl-1-(pentylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile

3-(3-hydroxypropylamino)-7-methyl-1-(pentylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile

C18H29N5O (331.2372)


   

1-[4-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]butyl]-3,5-dimethylpiperidine

1-[4-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]butyl]-3,5-dimethylpiperidine

C21H33NO2 (331.2511)


   

N-[(2S,3S,4R)-1,3,4-trihydroxy-15-methylhexadecan-2-yl]formamide

N-[(2S,3S,4R)-1,3,4-trihydroxy-15-methylhexadecan-2-yl]formamide

C18H37NO4 (331.2722)


   

Mono-(gamma-glutamyl) spermine

Mono-(gamma-glutamyl) spermine

C15H33N5O3 (331.2583)


   

2-adamantyl-[2-[[(2E)-3,7-dimethylocta-2,6-dienyl]amino]ethyl]azanium

2-adamantyl-[2-[[(2E)-3,7-dimethylocta-2,6-dienyl]amino]ethyl]azanium

C22H39N2+ (331.3113)


   

2-Aminononadecane-1,3,4-triol

2-Aminononadecane-1,3,4-triol

C19H41NO3 (331.3086)


   

Pyrrolidine, 1-(1-oxo-9,12,15-octadecatrienyl)-

Pyrrolidine, 1-(1-oxo-9,12,15-octadecatrienyl)-

C22H37NO (331.2875)


   

(2S)-2-[4-(1-Ethoxyethoxy)-1-hydroxybutyl]pyrrolidine-1-carboxylic acid tert-butyl ester

(2S)-2-[4-(1-Ethoxyethoxy)-1-hydroxybutyl]pyrrolidine-1-carboxylic acid tert-butyl ester

C17H33NO5 (331.2359)


   

all-cis-docosa-7,10,13,16-tetraenoate

all-cis-docosa-7,10,13,16-tetraenoate

C22H35O2 (331.2637)


A polyunsaturated fatty acid anion that is the conjugate base of all-cis-docosa-7,10,13,16-tetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

3-hydroxydecanoyl carnitine

3-hydroxydecanoyl carnitine

C17H33NO5 (331.2359)


   

N-ethyl arachidonoyl amine

N-ethyl arachidonoyl amine

C22H37NO (331.2875)


   
   
   

{[(2r,4ar,7r,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}methanimidic acid

{[(2r,4ar,7r,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}methanimidic acid

C21H33NO2 (331.2511)


   

3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoic acid

3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoic acid

C21H33NO2 (331.2511)


   

n-[4-(5-methyl-2-oxo-4-phenyl-1,5-diazocan-1-yl)butyl]ethanimidic acid

n-[4-(5-methyl-2-oxo-4-phenyl-1,5-diazocan-1-yl)butyl]ethanimidic acid

C19H29N3O2 (331.226)


   

1-[(1s,3s,3as,3br,7r,9ar,9bs,11ar)-7-amino-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3s,3as,3br,7r,9ar,9bs,11ar)-7-amino-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C21H33NO2 (331.2511)


   

[(7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl)oxy]methanimidic acid

[(7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl)oxy]methanimidic acid

C21H33NO2 (331.2511)


   

1-[(1s,3as,3br,5as,7r,9as,9bs,11ar)-9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3br,5as,7r,9as,9bs,11ar)-9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C22H37NO (331.2875)


   

{[(2r,4ar,7s,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}methanimidic acid

{[(2r,4ar,7s,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}methanimidic acid

C21H33NO2 (331.2511)


   

1-[9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C22H37NO (331.2875)


   

n,n'-bis(3,7-dimethylocta-2,6-dien-1-yl)guanidine

n,n'-bis(3,7-dimethylocta-2,6-dien-1-yl)guanidine

C21H37N3 (331.2987)


   

n,n'-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

n,n'-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

C21H37N3 (331.2987)


   

n,n-bis(3,7-dimethylocta-2,6-dien-1-yl)guanidine

n,n-bis(3,7-dimethylocta-2,6-dien-1-yl)guanidine

C21H37N3 (331.2987)


   

n-{4-[(4s)-5-methyl-2-oxo-4-phenyl-1,5-diazocan-1-yl]butyl}ethanimidic acid

n-{4-[(4s)-5-methyl-2-oxo-4-phenyl-1,5-diazocan-1-yl]butyl}ethanimidic acid

C19H29N3O2 (331.226)


   

1-{7-amino-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

1-{7-amino-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone

C21H33NO2 (331.2511)


   

2,5-dimethyl-3-(methylamino)-8-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalene-1,4-diol

2,5-dimethyl-3-(methylamino)-8-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalene-1,4-diol

C21H33NO2 (331.2511)


   

mycalenitrile-16

mycalenitrile-16

C22H37NO (331.2875)


   

1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-9a,11a-dimethyl-7-(methylamino)-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C22H37NO (331.2875)


   

n-benzylpentadecanimidic acid

n-benzylpentadecanimidic acid

C22H37NO (331.2875)


   

n-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-n-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

n-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-n-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

C21H37N3 (331.2987)


   

1-(6-hydroxy-8-phenyl-1,5,10-triazacyclotetradec-5-en-1-yl)ethanone

1-(6-hydroxy-8-phenyl-1,5,10-triazacyclotetradec-5-en-1-yl)ethanone

C19H29N3O2 (331.226)


   

n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C21H33NO2 (331.2511)


   

(5s,8r)-2,5-dimethyl-3-(methylamino)-8-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalene-1,4-diol

(5s,8r)-2,5-dimethyl-3-(methylamino)-8-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalene-1,4-diol

C21H33NO2 (331.2511)


   

3-[(1r,2r,3s,7r,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoic acid

3-[(1r,2r,3s,7r,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoic acid

C21H33NO2 (331.2511)


   

1-[(8s)-6-hydroxy-8-phenyl-1,5,10-triazacyclotetradec-5-en-1-yl]ethanone

1-[(8s)-6-hydroxy-8-phenyl-1,5,10-triazacyclotetradec-5-en-1-yl]ethanone

C19H29N3O2 (331.226)


   

[(1s,2r,7r,10s,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]acetic acid

[(1s,2r,7r,10s,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]acetic acid

C21H33NO2 (331.2511)


   

3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoic acid

3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoic acid

C21H33NO2 (331.2511)


   

(2z)-n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

(2z)-n-[2-(4-hydroxyphenyl)ethyl]-3-methyldodec-2-enimidic acid

C21H33NO2 (331.2511)


   

(2r,4s,5r,6s)-2-nonyl-6-phenyl-7-oxa-1-azabicyclo[3.2.1]octan-4-ol

(2r,4s,5r,6s)-2-nonyl-6-phenyl-7-oxa-1-azabicyclo[3.2.1]octan-4-ol

C21H33NO2 (331.2511)


   

(2r,3s,4s,6s)-6-(2-hydroxydodecyl)-2-(hydroxymethyl)piperidine-3,4-diol

(2r,3s,4s,6s)-6-(2-hydroxydodecyl)-2-(hydroxymethyl)piperidine-3,4-diol

C18H37NO4 (331.2722)


   

n,n-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

n,n-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

C21H37N3 (331.2987)


   

n,n'-bis[(2z)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

n,n'-bis[(2z)-3,7-dimethylocta-2,6-dien-1-yl]guanidine

C21H37N3 (331.2987)


   

(2s,3r,12r)-2-amino-3,12-dihydroxyoctadecanoic acid

(2s,3r,12r)-2-amino-3,12-dihydroxyoctadecanoic acid

C18H37NO4 (331.2722)